Premium
P15: Hematological adverse events as predictors of response to pegylated interferon and ribavirin treatment in patients with chronic hepatitis C genotype 4
Author(s) -
Taha A,
Hasan M,
Samir A,
Kandil A,
ElSisi E,
Yilmaz N
Publication year - 2013
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.12166_14
Subject(s) - ribavirin , medicine , neutropenia , pegylated interferon , adverse effect , anemia , gastroenterology , leukopenia , hepatitis c virus , immunology , chemotherapy , virus